Parameter | Recorded value | Standard value |
---|---|---|
White blood cell count, cells/L | 14.54 × 109 | 4.5–7.5 × 109 |
 Neutrophils, % | 34.0 | 42–74 |
 Eosinophil, % | 50.5 | 0–7.0 |
Hemoglobin, g/L | 102 | 113–152 |
Platelet count, cells/L | 6 × 109 | 130–350 × 109 |
Prothrombin time/International normalized ratio | 4.37 | 0.80–1.20 |
Activated partial thromboplastin time, s | 154.1 | 26.9–38.1 |
D-dimer, mg/L | 2.1 | < 1.0 |
Fibrin degradation product, mg/L | 3.6 | 0–5.0 |
Fibrinogen, g/L | 2.97 | 2.00–4.00 |
Antithrombin III, % | 37.2 | 70–120 |
C-reactive protein, nmol/L | 184.77 | ≤5.71 |
Total protein, g/L | 71 | 69–84 |
Albumin, g/L | 18 | 39–51 |
Total bilirubin, mmol/L | 0.0308 | 0.0034–0.0205 |
Aspartate aminotransferase, μkat/L | 0.32 | 0.18–0.5 |
Alanine aminotransferase, μkat/L | 0.47 | 0.07–0.5 |
Lactase dehydrogenase, μkat/L | 4.55 | 1.8–3.6 |
alkaline phosphatase, μkat/L | 25.02 | 1.67–5.83 |
γ- glutamyltransferase, μkat/L | 1.62 | 0.17–0.83 |
Creatine kinase, μkat/L | 0.93 | 0.67–2.5 |
Blood urea nitrogen, mmol/L | 9.43 | 2.86–7.14 |
Creatinine, mmol/L | 0.06 | 0.05–0.09 |
Sodium, mmol/L | 136 | 136–148 |
Potassium, mmol/L | 4.5 | 3.6–5.0 |
Chloride, mmol/L | 107 | 98–108 |
soluble interleukin-2 receptor, U/mL | 8540 | 140–520 |
IgG4, μmol/L | 28.62 | 0.33–7.80 |
IgE, U/mL | 20,367 | ≤173 |
P-ANCA | – |  |
C-ANCA | – |  |
Antinuclear antibody | 40 times | <  80 times |
C7-HRP | 0 | Â |
TAT, ng/mL | 2.6 | 0.0–3.9 |
PIC, μg/mL | < 0.2 | 0.0–0.8 |
Haptoglobin, mg/dL | 126 | 71–160 |
Activation of factor II, % | 49.1 | 66–118 |
Activation of factor V, % | < 1.0 | 73–122 |
Activation of factor X, % | 59.7 | 58–200 |
Protein C, % | 37% | 70–140% |
Protein S, % | 64.1% | 63–149% |
Cardiolipin antibody IgG, U/mL | 25 | 0–9 |
Cardiolipin antibody IgM, U/mL | 3 | 0–7 |
Anti-human beta-2 glycoprotein 1 Antibody, U/mL | < 1.3 | 0.0–3.4 |
lupus anticoagulant | Unknown | 0.0–1.2 |
Activation of ADAMTS13, % | 18 | ≥78 |